TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories
about
Comparisons of Primary HIV-1 Drug Resistance between Recent and Chronic HIV-1 Infection within a Sub-Regional Cohort of Asian PatientsTransmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia.HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in AsiaComparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis.HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study.Japanese external quality assessment program to standardize HIV-1 drug-resistance testing (JEQS2010 program) using in vitro transcribed RNA as reference material.Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.Sequence quality analysis tool for HIV type 1 protease and reverse transcriptase.Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa.Global analysis of sequence diversity within HIV-1 subtypes across geographic regions.Estimating time of HIV-1 infection from next-generation sequence diversity.Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.Declining trend in transmitted drug resistance detected in a prospective cohort study of acute HIV infection in Bangkok, Thailand.
P2860
Q28534376-B5E3F0C9-05DD-4C73-ADEA-29124DD83E49Q33820125-5EA1F92B-EBDC-430F-82E4-5833993D8063Q34072721-87B8B0AC-DF48-40A8-B8DA-D06A60463A8DQ34457230-EB16AE04-E512-4ADA-A43F-DE9C744B0C80Q34756828-207E0F58-00C2-455C-9F35-B764569DF7E2Q35141797-E1C038F8-8B4F-4C1C-BFEF-F7F1DCC8C5B2Q35832732-F5787C31-6B67-460F-A8E7-39E1CE1BBD06Q36102542-BD8BF5DB-8026-402B-B8DA-D5D66010785AQ37005868-F680EA43-7B24-4949-A257-9AFA13930136Q39581763-B25AE648-802A-4F8A-8DE2-17A105DE5BAEQ41926717-5D6AEC25-D2A5-4BBA-9B98-9321159FFACEQ42262381-842D6FA1-10AB-498C-9116-D279BDE63C9EQ42376265-F27F1CB4-1880-4694-8BA2-F1940AC51C79
P2860
TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
TREAT Asia Quality Assessment ...... a group of Asian laboratories
@ast
TREAT Asia Quality Assessment ...... a group of Asian laboratories
@en
type
label
TREAT Asia Quality Assessment ...... a group of Asian laboratories
@ast
TREAT Asia Quality Assessment ...... a group of Asian laboratories
@en
prefLabel
TREAT Asia Quality Assessment ...... a group of Asian laboratories
@ast
TREAT Asia Quality Assessment ...... a group of Asian laboratories
@en
P2093
P2860
P1476
TREAT Asia Quality Assessment ...... a group of Asian laboratories
@en
P2093
Allison DeLong
David Katzenstein
David Sayer
Elizabeth M Dax
Jeffery Smith
Jialun Zhou
Kevin Frost
Philip Cunningham
Rami Kantor
Sally Land
P2860
P304
P356
10.1016/J.JVIROMET.2009.03.016
P577
2009-03-26T00:00:00Z